Evidence map›Paper›PMID 41733879›Full record

ReviewMedScience2026

Paligenosis: dual potential of mature cell plasticity in regeneration and tumorigenesis.

Fan Xue, Yue Liang, Yi-Fu Miao, Che Liu, Zhi-Feng Miao, Zhen-Ning Wang

Abstract readReview
PubMed Publisher
In one paragraph

Review in MedScience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Fan Xue *Department of Surgical Oncology and General Surgery, The First Affiliated Hospital of China Medical University, Shenyang, 110001, China.
Yue Liang *Department of First Digestive Endoscopy, The Fourth Affiliated Hospital of China Medical University, Shenyang, 110032, China.
Yi-Fu MiaoDepartment of Surgical Oncology and General Surgery, The First Affiliated Hospital of China Medical University, Shenyang, 110001, China.
Che LiuDepartment of Surgical Oncology and General Surgery, The First Affiliated Hospital of China Medical University, Shenyang, 110001, China.
Zhi-Feng MiaoDepartment of Surgical Oncology and General Surgery, The First Affiliated Hospital of China Medical University, Shenyang, 110001, China. zfmiao@cmu.edu.cn.
Zhen-Ning WangDepartment of Surgical Oncology and General Surgery, The First Affiliated Hospital of China Medical University, Shenyang, 110001, China. znwang@cmu.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Paligenosis is an emerging model of mature cell plasticity that enables terminally differentiated cells to re-enter the cell cycle and contribute to tissue regeneration following injury. This tightly regulated process involves an initial phase of autophagy-mediated organelle clearance coupled with mechanistic target of rapamycin complex 1 (mTORC1) suppression, followed by mTORC1 reactivation and stemness gene induction that establishes regenerative competence, ultimately culminating in proliferation and lineage restoration. While paligenosis provides an adaptive mechanism to rapidly replenish lost cells in tissues such as the stomach and pancreas, persistent activation under chronic stress or oncogenic signals may drive metaplasia and tumor initiation. Recent evidence further implicates paligenosis-like programs in cancer progression, metastasis, and therapy resistance, underscoring its dual roles in regeneration and disease. Ongoing investigation into the molecular circuitry of paligenosis-including metabolic rewiring, canonical signaling, and epigenetic remodeling-may yield new insights into both tissue repair and oncogenic transformation, offering novel opportunities for therapeutic targeting.

Indexed as

CarcinogenesisCell PlasticityCell Transformation, NeoplasticRegenerationAnimalsAutophagyHumansMechanistic Target of Rapamycin Complex 1Signal TransductionMechanistic Target of Rapamycin Complex 1autophagycellular plasticitymTORC1 signalingpaligenosisregenerationtumorigenesis

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.